242 related articles for article (PubMed ID: 25374230)
1. High monocarboxylate transporter 4 protein expression in stromal cells predicts adverse survival in gastric cancer.
Yan P; Li YH; Tang ZJ; Shu X; Liu X
Asian Pac J Cancer Prev; 2014; 15(20):8923-9. PubMed ID: 25374230
[TBL] [Abstract][Full Text] [Related]
2. Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome.
Doyen J; Trastour C; Ettore F; Peyrottes I; Toussant N; Gal J; Ilc K; Roux D; Parks SK; Ferrero JM; Pouysségur J
Biochem Biophys Res Commun; 2014 Aug; 451(1):54-61. PubMed ID: 25058459
[TBL] [Abstract][Full Text] [Related]
3. Stromal-epithelial metabolic coupling in gastric cancer: stromal MCT4 and mitochondrial TOMM20 as poor prognostic factors.
Zhao Z; Han F; He Y; Yang S; Hua L; Wu J; Zhan W
Eur J Surg Oncol; 2014 Oct; 40(10):1361-8. PubMed ID: 24821064
[TBL] [Abstract][Full Text] [Related]
4. Expression of hypoxic marker carbonic anhydrase IX predicts poor prognosis in resectable hepatocellular carcinoma.
Huang WJ; Jeng YM; Lai HS; Fong IU; Sheu FY; Lai PL; Yuan RH
PLoS One; 2015; 10(3):e0119181. PubMed ID: 25738958
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of carbonic anhydrase IX (CA-IX), endoglin (CD105) and 8-hydroxy-2'-deoxyguanosine (8-OHdG) in breast cancer patients.
Beketic-Oreskovic L; Ozretic P; Rabbani ZN; Jackson IL; Sarcevic B; Levanat S; Maric P; Babic I; Vujaskovic Z
Pathol Oncol Res; 2011 Sep; 17(3):593-603. PubMed ID: 21249485
[TBL] [Abstract][Full Text] [Related]
6. The expression of metabolism-related proteins in phyllodes tumors.
Kwon JE; Jung WH; Koo JS
Tumour Biol; 2013 Feb; 34(1):115-24. PubMed ID: 22986897
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of carbonic anhydrase IX expression by cancer-associated fibroblasts in lung adenocarcinoma.
Nakao M; Ishii G; Nagai K; Kawase A; Kenmotsu H; Kon-No H; Hishida T; Nishimura M; Yoshida J; Ochiai A
Cancer; 2009 Jun; 115(12):2732-43. PubMed ID: 19365853
[TBL] [Abstract][Full Text] [Related]
8. Glucose metabolism in NSCLC is histology-specific and diverges the prognostic potential of 18FDG-PET for adenocarcinoma and squamous cell carcinoma.
Schuurbiers OC; Meijer TW; Kaanders JH; Looijen-Salamon MG; de Geus-Oei LF; van der Drift MA; van der Heijden EH; Oyen WJ; Visser EP; Span PN; Bussink J
J Thorac Oncol; 2014 Oct; 9(10):1485-93. PubMed ID: 25170642
[TBL] [Abstract][Full Text] [Related]
9. Loss of ACSS2 expression predicts poor prognosis in patients with gastric cancer.
Hur H; Kim YB; Ham IH; Lee D
J Surg Oncol; 2015 Nov; 112(6):585-91. PubMed ID: 26381042
[TBL] [Abstract][Full Text] [Related]
10. Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas.
Driessen A; Landuyt W; Pastorekova S; Moons J; Goethals L; Haustermans K; Nafteux P; Penninckx F; Geboes K; Lerut T; Ectors N
Ann Surg; 2006 Mar; 243(3):334-40. PubMed ID: 16495697
[TBL] [Abstract][Full Text] [Related]
11. HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome.
Trastour C; Benizri E; Ettore F; Ramaioli A; Chamorey E; Pouysségur J; Berra E
Int J Cancer; 2007 Apr; 120(7):1451-8. PubMed ID: 17245699
[TBL] [Abstract][Full Text] [Related]
12. Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis.
Haapasalo JA; Nordfors KM; Hilvo M; Rantala IJ; Soini Y; Parkkila AK; Pastoreková S; Pastorek J; Parkkila SM; Haapasalo HK
Clin Cancer Res; 2006 Jan; 12(2):473-7. PubMed ID: 16428489
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy.
Aydin D; Bilici A; Yavuzer D; Kefeli U; Tan A; Ercelep O; Mert A; Yuksel S; Ozcelik M; Isik D; Surmeli H; Odabasi H; Aliustaoglu M
Clin Transl Oncol; 2015 Aug; 17(8):604-11. PubMed ID: 25786367
[TBL] [Abstract][Full Text] [Related]
14. Monocarboxylate transporters MCT1 and MCT4 are independent prognostic biomarkers for the survival of patients with clear cell renal cell carcinoma and those receiving therapy targeting angiogenesis.
Cao YW; Liu Y; Dong Z; Guo L; Kang EH; Wang YH; Zhang W; Niu HT
Urol Oncol; 2018 Jun; 36(6):311.e15-311.e25. PubMed ID: 29657088
[TBL] [Abstract][Full Text] [Related]
15. MCT4 Expression Is a Potential Therapeutic Target in Colorectal Cancer with Peritoneal Carcinomatosis.
Kim HK; Lee I; Bang H; Kim HC; Lee WY; Yun SH; Lee J; Lee SJ; Park YS; Kim KM; Kang WK
Mol Cancer Ther; 2018 Apr; 17(4):838-848. PubMed ID: 29483215
[TBL] [Abstract][Full Text] [Related]
16. Endocervical glandular neoplasia associated with lobular endocervical glandular hyperplasia is HPV-independent and correlates with carbonic anhydrase-IX expression: a Gynaecological Oncology Group Study.
Liao SY; Rodgers WH; Kauderer J; Darcy KM; Carter R; Susumu N; Nagao S; Walker JL; Hatae M; Stanbridge EJ
Br J Cancer; 2013 Feb; 108(3):613-20. PubMed ID: 23299542
[TBL] [Abstract][Full Text] [Related]
17. Expression of monocarboxylate transporter (MCT)-4 in colorectal cancer and its role: MCT4 contributes to the growth of colorectal cancer with vascular endothelial growth factor.
Gotanda Y; Akagi Y; Kawahara A; Kinugasa T; Yoshida T; Ryu Y; Shiratsuchi I; Kage M; Shirouzu K
Anticancer Res; 2013 Jul; 33(7):2941-7. PubMed ID: 23780984
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase IX in early-stage non-small cell lung cancer.
Kim SJ; Rabbani ZN; Vollmer RT; Schreiber EG; Oosterwijk E; Dewhirst MW; Vujaskovic Z; Kelley MJ
Clin Cancer Res; 2004 Dec; 10(23):7925-33. PubMed ID: 15585626
[TBL] [Abstract][Full Text] [Related]
19. A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells.
Mboge MY; Chen Z; Khokhar D; Wolff A; Ai L; Heldermon CD; Bozdag M; Carta F; Supuran CT; Brown KD; McKenna R; Frost CJ; Frost SC
Biochem J; 2019 May; 476(10):1497-1513. PubMed ID: 31072911
[TBL] [Abstract][Full Text] [Related]
20. Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients.
Li G; Xu J; Wang Z; Yuan Y; Li Y; Cai S; He Y
J Cancer Res Clin Oncol; 2015 Mar; 141(3):443-52. PubMed ID: 25261987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
